(Q34153529)

31 July 2017

Can racial disparities in optimal gout treatment be reduced? Evidence from a randomized trial (English)

1 reference

31 July 2017

Jasvinder A Singh

1

0 references

language of work or name

English

0 references

publication date

9 February 2012

1 reference

31 July 2017

1 reference

31 July 2017

10

1 reference

31 July 2017

15

1 reference

https://scigraph.springernature.com/pub.10.1186/1741-7015-10-15

31 July 2017

0 references

cites work

African American patients with gout: efficacy and safety of febuxostat vs allopurinol

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3337326

Breakout session: Ethnic and racial disparities in joint arthroplasty

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3337326

Ethnic and racial factors influencing well-being, perceived pain, and physical function after primary total joint arthroplasty

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3337326

5 July 2018

Clinical practice. Gout

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3337326

Independent impact of gout on the risk of acute myocardial infarction among elderly women: a population-based study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3337326

Racial disparities in treatment preferences for rheumatoid arthritis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3337326

Febuxostat in the treatment of gout: 5-yr findings of the FOCUS efficacy and safety study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3337326

The effect of serum urate on gout flares and their associated costs: an administrative claims analysis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3337326

Long-term cardiovascular mortality among middle-aged men with gout

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3337326

Gout and the risk of acute myocardial infarction

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3337326

Serum urate levels and gout flares: analysis from managed care data

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3337326

A retrospective study of the relationship between serum urate level and recurrent attacks of gouty arthritis: evidence for reduction of recurrent gouty arthritis with antihyperuricemic therapy

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3337326

Quality of care indicators for gout management

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3337326

Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I.

5 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-10-15

Opportunities for improving medication use and monitoring in gout.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-10-15

Clinical efficacy and safety of successful longterm urate lowering with febuxostat or allopurinol in subjects with gout

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-10-15

Determinants of the clinical outcomes of gout during the first year of urate-lowering therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-10-15

Racial, ethnic, and geographic disparities in rates of knee arthroplasty among Medicare patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-10-15

Gout in ambulatory care settings in the United States

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3337326

Unequal treatment: confronting racial and ethnic disparities in health care

28 October 2018

1 reference

12 December 2020

Increasing prevalence of gout and hyperuricemia over 10 years among older adults in a managed care population

1 reference

12 December 2020

Racial differences in the incidence of gout. The role of hypertension

1 reference

12 December 2020

Gout medication treatment patterns and adherence to standards of care from a managed care perspective

1 reference

12 December 2020

Dose adjustment of allopurinol according to creatinine clearance does not provide adequate control of hyperuricemia in patients with gout

1 reference

12 December 2020

Independent impact of gout on mortality and risk for coronary heart disease

1 reference

12 December 2020

Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007-2008

1 reference

12 December 2020

Identifiers

DOI

10.1186/1741-7015-10-15

1 reference

PubMed ID

22316088

Dimensions Publication ID

31 July 2017

0 references

1 reference

31 July 2017

1 reference

PubMed ID

22316088